Civic Intelligence

Answer2Cancer

EIN 81-4885713 • 501(c)3 • Beaverton, OR

Pub. 78 Eligible

Profile

Answer2Cancer, Inc. is by and for patients who, while going through cancer treatments, realized they didn't know what they didn't know. Those undergoing treatment (and their caregivers) know there is so much to know. Answer2Cancer, Inc. has been created to help patients and their caregivers/helpers overcome the challenges of treatments and learn helpful, healthful survivor strategies.

7299 SW Linette WayBeaverton, OR 97007

www.answer2cancer.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

85th percentile

0.29x

Higher debt load relative to assets than 85% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

95th percentile

1.05x

Higher debt load relative to revenue than 95% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

95th percentile

76%

Higher net margin than 95% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

84th percentile

$0

Higher top officer pay than 84% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

80th percentile

26%

Faster asset growth than 80% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

97th percentile

373%

Faster revenue growth than 97% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets85th percentile

Assets

Up

$36,892

Up $7,618 (+26%) from 2023

Liabilities

Flat

$10,522

Flat from 2023

Net Assets

Up

$26,370

Up $7,618 (+41%) from 2023

Operations
Liabilities / Revenue95th percentileNet Margin95th percentile

Revenue

Up

$10,050

Up $7,924 (+373%) from 2023

Expenses

Down

$2,432

Down $1,506 (-38%) from 2023

Net Income

Up

$7,618

Up $9,430 (+520%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth80th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$40K$30K$20K$10K$0Assets 2017: $2,702Liabilities 2017: $02017Assets 2018: $12,274Liabilities 2018: $9,135Net Assets 2018: $3,1392018Assets 2019: $14,766Liabilities 2019: $7,6352019Assets 2020: $14,766Liabilities 2020: $8,3592020Assets 2021: $27,347Liabilities 2021: $14,345Net Assets 2021: $13,0022021Assets 2022: $31,086Liabilities 2022: $10,522Net Assets 2022: $20,5642022Assets 2023: $29,274Liabilities 2023: $10,522Net Assets 2023: $18,7522023Assets 2024: $36,892Liabilities 2024: $10,522Net Assets 2024: $26,3702024

Highlighted filing

2024

Assets$36,892
Liabilities$10,522
Net Assets$26,370
Open 2024 Filing

Operations Trend

Revenue Growth97th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$80K$60K$40K$20K$0-$20KRevenue 2017: $7,500Expenses 2017: $4,798Net Income 2017: $2,7022017Revenue 2018: $63,739Expenses 2018: $63,303Net Income 2018: $4362018Revenue 2019: $11,092Expenses 2019: $7,824Net Income 2019: $3,2682019Revenue 2020: $11,092Expenses 2020: $7,824Net Income 2020: $3,2682020Revenue 2021: $9,144Expenses 2021: $3,059Net Income 2021: $6,0852021Revenue 2022: $7,800Expenses 2022: $6,225Net Income 2022: $1,5752022Revenue 2023: $2,126Expenses 2023: $3,938Net Income 2023: -$1,8122023Revenue 2024: $10,050Expenses 2024: $2,432Net Income 2024: $7,6182024

Highlighted filing

2024

Revenue$10,050
Expenses$2,432
Net Income$7,618
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$36,892
Liabilities
$10,522
Net assets
$26,370
Revenue
$10,050
Expenses
$2,432
Net income
$7,618
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$36.9$10.5$26.4$10.1$2.43$7.62
2023Detailed filing. Detailed filing data is available for this year.$29.3$10.5$18.8$2.13$3.94$1.81
2022Detailed filing. Detailed filing data is available for this year.$31.1$10.5$20.6$7.80$6.23$1.58
2021Detailed filing. Detailed filing data is available for this year.$27.3$14.3$13.0$9.14$3.06$6.09
2020Summary only. Only limited summary data is available for this year.$14.8$8.36$11.1$7.82$3.27
2019Summary only. Only limited summary data is available for this year.$14.8$7.64$11.1$7.82$3.27
2018Detailed filing. Detailed filing data is available for this year.$12.3$9.14$3.14$63.7$63.3$0.44
2017Summary only. Only limited summary data is available for this year.$2.70$0.00$7.50$4.80$2.70
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
May 14, 2025
Return Version
2024v5.0
Gross Receipts
$10,050
Mission and Program Overview

Mission

Answer2Cancer, Inc. is by and for patients who, while going through cancer treatments, realized they didn't know what they didn't know. Those undergoing treatment (and their caregivers) know there is so much to know. Answer2Cancer, Inc. has been created to help patients and their caregivers/helpers overcome the challenges of treatments and learn helpful, healthful survivor strategies.

Program Services

DescriptionGrantsExpenses
In 2018, we held Answer2Cancer, Inc. full day event to bring resources, support and education at no charge to Portland, Oregon area cancer patients, their families and caregivers. Nearly 300 people attended the April 7, 2018 event. We also made presentations to community and health groups including Portland Oncology Pharmeceutical Society's leadership team. Additionally, we traveled to and began planning for 2019 and 2020 events in Bellingham, Spokane and the Tri-Cities, Washington. The 2020 event due to COVID-19, was held through an on-line format to reach those who were at higher risk due to suppressed immune systems. The event was held on October 3, 2020 and was title "Answer2Cancer Digital 2020" The event was attended by approximately 275 on-line attendees. In 2021, the focus of the year was education and outreach planning for events in 2022 and 2023.$0$0
Activities and planning 2022-responded and wrote two small Advocacy grants to Pfizer and also applied for Advocate grant from PhRMA. In, October of 2022 traveled to Missoula and Billings Montana regarding the possibility of bringing the A2C program to MT in 2023. Received a favorable reception at both locations from representatives of Johnson & Johnson and the American Cancer Society's Cancer Action Network local director. Following up with Community Cancer Centers In MT and other organizations to begin the process for a summer 2023 event. In October of 2022, also traveled to Boise, ID meeting with a clinical trial specialist who is affiliated with a large health care system there at St. Luke's.$0$0
In 2023, we continued planning for 2024 patient education and support events in Eugene, Billings Montana and Boise Idaho. We worked closely with therapeutical companies to engage in patient education efforts with local health providers, policymakers and patient advocate organizations, to improve access to medicines for the underserved.$0$0
A2C was invited to submit an Advocacy grant to Pfizer, which was funded at $10,000. Funds are being used on a digital media to support/increase awareness of a national patient survey to determine drug cost variables for patients and families. For 2025, working on a pitch for an A2C event in Eugene, in cooperation with the Willamette Valley Cancer institute in Eugene and throughout Lane County$0$0
Compensation and Service Providers
Top Officer Pay84th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Dianne J Danowski-SmithPresidentPT$0--
Andrew D SmithCFO-$0--
Elaine DenningSecretaryPT$0--
Rosemary McDermottNursing ConsultantPT$0--
Filing and Contact Details

Filer

Filer Name
Answer2cancer
EIN
81-4885713
Phone
5032017019
Address
7299 SW Linette Way, Beaverton, OR 97007

Signing Officer

Name
Andrew Smith
Title
CFO
Phone
5036469854
Signed
2025-05-14
Supplemental Narrative

Additional Explanations

Form 990-EZ, Part I, Line 10

“Donation to Caring Ambassadors”

Form 990-EZ, Part I, Line 16

“Description;Amount^Vimeo Video Subscription paid to Visa;240|Spotify;192^Total;432^”

Form 990-EZ, Part II, Line 26

“Description;EOY Amount^Payable to officers A2C at Inception;10522^Total;10522^”

Raw XML Appendix187 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BenefitsPaidToOrForMembersAmt00
IRS990EZ/BooksInCareOfDetail/PersonNm0Dianne J Danowski-Smith-A Smith
IRS990EZ/BooksInCareOfDetail/PhoneNum05032017019
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt07299 SW Linette Way
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Beaverton
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0OR
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd097007
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt029274
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt036892
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt010049
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt07618
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt00
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form1120PolFiledInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt029274
IRS990EZ/Form990TotalAssetsGrp/EOYAmt036892
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GainOrLossFromSaleOfAssetsAmt00
IRS990EZ/GamingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt02000
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt010050
IRS990EZ/GrossSalesOfInventoryAmt00
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt01
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MembershipDuesAmt00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt018752
IRS990EZ/NetAssetsOrFundBalancesEOYAmt026370
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt018752
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt026370
IRS990EZ/OccupancyRentUtltsAndMaintAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt010
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt25
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt35
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Dianne J Danowski-Smith
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Andrew D Smith
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Elaine Denning
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Rosemary McDermott
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1CFO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Secretary
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Nursing Consultant
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt00
IRS990EZ/OtherAssetsTotalDetail/EOYAmt00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt0432
IRS990EZ/OtherRevenueTotalAmt00
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0Answer2Cancer, Inc. is by and for patients who, while going through cancer treatments, realized they didn't know what they didn't know. Those undergoing treatment (and their caregivers) know there is so much to know. Answer2Cancer, Inc. has been created to help patients and their caregivers/helpers overcome the challenges of treatments and learn helpful, healthful survivor strategies.
IRS990EZ/PrintingPublicationsPostageAmt00
IRS990EZ/ProgramServiceRevenueAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0In 2018, we held Answer2Cancer, Inc. full day event to bring resources, support and education at no charge to Portland, Oregon area cancer patients, their families and caregivers. Nearly 300 people attended the April 7, 2018 event. We also made presentations to community and health groups including Portland Oncology Pharmeceutical Society's leadership team. Additionally, we traveled to and began planning for 2019 and 2020 events in Bellingham, Spokane and the Tri-Cities, Washington. The 2020 event due to COVID-19, was held through an on-line format to reach those who were at higher risk due to suppressed immune systems. The event was held on October 3, 2020 and was title "Answer2Cancer Digital 2020" The event was attended by approximately 275 on-line attendees. In 2021, the focus of the year was education and outreach planning for events in 2022 and 2023.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1Activities and planning 2022-responded and wrote two small Advocacy grants to Pfizer and also applied for Advocate grant from PhRMA. In, October of 2022 traveled to Missoula and Billings Montana regarding the possibility of bringing the A2C program to MT in 2023. Received a favorable reception at both locations from representatives of Johnson & Johnson and the American Cancer Society's Cancer Action Network local director. Following up with Community Cancer Centers In MT and other organizations to begin the process for a summer 2023 event. In October of 2022, also traveled to Boise, ID meeting with a clinical trial specialist who is affiliated with a large health care system there at St. Luke's.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt2In 2023, we continued planning for 2024 patient education and support events in Eugene, Billings Montana and Boise Idaho. We worked closely with therapeutical companies to engage in patient education efforts with local health providers, policymakers and patient advocate organizations, to improve access to medicines for the underserved.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt3A2C was invited to submit an Advocacy grant to Pfizer, which was funded at $10,000. Funds are being used on a digital media to support/increase awareness of a national patient survey to determine drug cost variables for patients and families. For 2025, working on a pitch for an A2C event in Eugene, in cooperation with the Willamette Valley Cancer institute in Eugene and throughout Lane County
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt20
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt30
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt10
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt20
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt30
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt00
IRS990EZ/SaleOfAssetsGrossAmt00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SpecialEventsNetIncomeLossAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0OR
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt010522
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt010522
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt02432
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt010050
IRS990EZ/TransactionWithControlEntInd00
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0www.answer2cancer.org
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt010049
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02125
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt07799
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt09142
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt041418
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt070533
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt01
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt01
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt01
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt03
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.99996
IRS990ScheduleA/PublicSupportPY170Pct00.99997
IRS990ScheduleA/PublicSupportTotal170Amt070533
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus2YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt010049
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02125
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt07799
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt09142
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt041418
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt070533
IRS990ScheduleA/TotalSupportAmt070536
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Donation to Caring Ambassadors
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Description;Amount^Vimeo Video Subscription paid to Visa;240|Spotify;192^Total;432^
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Description;EOY Amount^Payable to officers A2C at Inception;10522^Total;10522^
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990-EZ, Part I, Line 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990-EZ, Part I, Line 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990-EZ, Part II, Line 26
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Andrew Smith
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CFO
ReturnHeader/BusinessOfficerGrp/PhoneNum05036469854
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-14
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ANSWER2CANCER
ReturnHeader/Filer/BusinessNameControlTxt0ANSW
ReturnHeader/Filer/EIN0814885713
ReturnHeader/Filer/PhoneNum05032017019
ReturnHeader/Filer/USAddress/AddressLine1Txt07299 SW Linette Way
ReturnHeader/Filer/USAddress/CityNm0Beaverton
ReturnHeader/Filer/USAddress/StateAbbreviationCd0OR
ReturnHeader/Filer/USAddress/ZIPCd097007
ReturnHeader/IRSResponsiblePrtyInfoCurrInd01
ReturnHeader/ReturnTs02025-05-14T21:53:19-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.